Trial Profile
Second Generation" Drug-Eluting Stents Implantation followed by Six versus Twelve-Month - Dual Antiplatelet Therapy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary artery disease; Coronary stent thrombosis
- Focus Therapeutic Use
- Acronyms SECURITY
- 03 Feb 2014 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 13 Aug 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 29 Jul 2009 New trial record